148 related articles for article (PubMed ID: 8946558)
1. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression.
Wlodarczyk BJ; Bennett GD; Calvin JA; Finnell RH
Reprod Toxicol; 1996; 10(6):447-54. PubMed ID: 8946558
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos [corrected].
Bennett GD; Wlodarczyk B; Calvin JA; Craig JC; Finnell RH
Reprod Toxicol; 2000; 14(1):1-11. PubMed ID: 10689198
[TBL] [Abstract][Full Text] [Related]
3. Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos.
Carpenter SJ
Anat Embryol (Berl); 1987; 176(3):345-65. PubMed ID: 3631535
[TBL] [Abstract][Full Text] [Related]
4. Phenytoin-induced teratogenesis: a molecular basis for the observed developmental delay during neurulation.
Bennett GD; Lau F; Calvin JA; Finnell RH
Epilepsia; 1997 Apr; 38(4):415-23. PubMed ID: 9118846
[TBL] [Abstract][Full Text] [Related]
5. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos.
Wlodarczyk BJ; Cabrera RM; Hill DS; Bozinov D; Zhu H; Finnell RH
Neurotoxicology; 2006 Jul; 27(4):547-57. PubMed ID: 16620997
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-induced congenital malformations in genetically susceptible folate binding protein-2 knockout mice.
Wlodarczyk B; Spiegelstein O; Gelineau-van Waes J; Vorce RL; Lu X; Le CX; Finnell RH
Toxicol Appl Pharmacol; 2001 Dec; 177(3):238-46. PubMed ID: 11749123
[TBL] [Abstract][Full Text] [Related]
7. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model.
Hill DS; Wlodarczyk BJ; Finnell RH
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):40-7. PubMed ID: 18186108
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in utero development.
Stump DG; Holson JF; Fleeman TL; Nemec MD; Farr CH
Teratology; 1999 Nov; 60(5):283-91. PubMed ID: 10525206
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid-induced changes in gene expression during neurulation in a mouse model.
Wlodarczyk BC; Craig JC; Bennett GD; Calvin JA; Finnell RH
Teratology; 1996 Dec; 54(6):284-97. PubMed ID: 9098922
[TBL] [Abstract][Full Text] [Related]
10. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
[TBL] [Abstract][Full Text] [Related]
11. Effects of folate supplementation on the risk of spontaneous and induced neural tube defects in Splotch mice.
Gefrides LA; Bennett GD; Finnell RH
Teratology; 2002 Feb; 65(2):63-9. PubMed ID: 11857507
[TBL] [Abstract][Full Text] [Related]
12. Lack of concordance between heat shock proteins and the development of tolerance to teratogen-induced neural tube defects.
Finnell RH; Van Waes M; Bennett GD; Eberwine JH
Dev Genet; 1993; 14(2):137-47. PubMed ID: 8482018
[TBL] [Abstract][Full Text] [Related]
13. Cadmium-induced differential toxicogenomic response in resistant and sensitive mouse strains undergoing neurulation.
Robinson JF; Yu X; Hong S; Griffith WC; Beyer R; Kim E; Faustman EM
Toxicol Sci; 2009 Jan; 107(1):206-19. PubMed ID: 18974090
[TBL] [Abstract][Full Text] [Related]
14. Arsenic- and cadmium-induced toxicogenomic response in mouse embryos undergoing neurulation.
Robinson JF; Yu X; Moreira EG; Hong S; Faustman EM
Toxicol Appl Pharmacol; 2011 Jan; 250(2):117-29. PubMed ID: 20883709
[TBL] [Abstract][Full Text] [Related]
15. Neurulation abnormalities secondary to altered gene expression in neural tube defect susceptible Splotch embryos.
Bennett GD; An J; Craig JC; Gefrides LA; Calvin JA; Finnell RH
Teratology; 1998 Jan; 57(1):17-29. PubMed ID: 9516748
[TBL] [Abstract][Full Text] [Related]
16. Impact of prenatal arsenate exposure on gene expression in a pure population of migratory cranial neural crest cells.
Mukhopadhyay P; Seelan RS; Greene RM; Pisano MM
Reprod Toxicol; 2019 Jun; 86():76-85. PubMed ID: 30953684
[TBL] [Abstract][Full Text] [Related]
17. Arsenic-induced alterations in embryonic transcription factor gene expression: implications for abnormal neural development.
Wlodraczyk B; Bennett GD; Calvin JA; Craig JC; Finnell RH
Dev Genet; 1996; 18(4):306-15. PubMed ID: 8754282
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with periodate-oxidized adenosine enhances developmental toxicity of inorganic arsenic in mice.
Lammon CA; Le XC; Hood RD
Birth Defects Res B Dev Reprod Toxicol; 2003 Aug; 68(4):335-43. PubMed ID: 14666996
[TBL] [Abstract][Full Text] [Related]
19. Arsenic-induced axial skeletal (dysraphic) disorders.
Willhite CC
Exp Mol Pathol; 1981 Apr; 34(2):145-58. PubMed ID: 6894125
[No Abstract] [Full Text] [Related]
20. Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model.
Hill DS; Wlodarczyk BJ; Mitchell LE; Finnell RH
Toxicol Appl Pharmacol; 2009 Aug; 239(1):29-36. PubMed ID: 19446573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
